NYSE · LLY
Eli Lilly and Company
$1,416.35+$42.65 (+3.1%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.3% below the high.
Loading market information…
OTC · MSGP · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
MedSmart Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
MedSmart Group Inc. oversees a network of professional MedSmart wellness centers, primarily dedicated to providing anti-aging solutions. Their comprehensive suite of services includes hormone replacement therapies, such as testosterone replacement and general hormone restoration, cryogen therapy, and treatments for various health issues like hypothyroidism, allergies, high cholesterol, hypertension, and diabetes. Furthermore, the centers offer specialized programs like the Smart Diet and Medi-Fast, alongside aesthetic and health-related procedures, including vein treatment, laser hair removal, hair loss solutions, and erectile dysfunction treatment. The company's headquarters are situated in Bay Harbor Islands, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:15 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,416.35+$42.65 (+3.1%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.3% below the high.
$0.00$0.00 (0.0%)
Upper Street Marketing Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Better Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Panacos Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Inyx, Inc.: Healthcare · Medical - Pharmaceuticals.
$0.00$0.00 (0.0%)
Sunridge International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.49% below the high.
$0.00$0.00 (0.0%)
SpectraScience, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
Viveve Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
